key: cord-0793535-bxl013v1 authors: Yang, Nan; Tian, Kunming; Jin, Meng; Zhang, Xu; Zhang, Fengqin; Shi, Xiuquan; Wang, Xiaoyang; Niu, Siyuan; Shi, Jing; Hu, Ke; Liu, Kui; Peng, Ping; Wang, Ying; Zhang, Huilan; Tian, Jianbo title: Sudden death of COVID-19 patients in Wuhan, China: A retrospective cohort study date: 2021-03-27 journal: Journal of global health DOI: 10.7189/jogh.11.05006 sha: c44ba20752ab52706c99a92722b2a900cf8c41a6 doc_id: 793535 cord_uid: bxl013v1 BACKGROUND: In December 2019, coronavirus disease 2019 (COVID-19) emerged in Wuhan city and rapidly spread throughout China. So far, it has caused ~ 4000 deaths in this country. We aimed to systematically characterize clinical features and determine risk factors of sudden death for COVID-19 patients. METHODS: Deceased patients with COVID-19 in Tongji hospital from January 22 to March 23, 2020 were extracted. Patients who died within 24 hours after admission were identified as sudden deaths, and the others formed non-sudden deaths. The differences in clinical characteristics between the two groups were estimated. Risk factors associated with sudden deaths were explored by logistic regression. RESULTS: 281 deceased patients were enrolled in this study. Sudden death occurred in 28 (10.0%) patients, including 4 (14.3%) admitted to the intensive care unit. Fatigue was more common in sudden deaths (11, 47.8%) than in non-sudden deaths (40, 17.2%). Both the count and percentage of eosinophils were lower in sudden deaths than that in non-sudden deaths (P = 0.006 and P = 0.004). Compared with non-sudden deaths, sudden deaths had higher plasma levels of procalcitonin, C-reactive protein, D-dimer, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transferase, lactate dehydrogenase, alkaline phosphatase and N-terminal pro-brain natriuretic peptide. There were not significant differences in gender, age, chest CT image features and comorbidities observed. CONCLUSIONS: The differences between the two groups suggested more severe systemic inflammation, multi-organ dysfunction, especially impaired liver and heart function in COVID-19 patients who died suddenly after admission. More researches are needed to verify these points. In December 2019, a series of pneumonia cases of unknown cause were identified in Wuhan, China [1] . This pneumonia, later named as coronavirus disease 2019 (COVID-19) by WHO, was caused by a novel enveloped RNA betacoronavirus, SARS-CoV-2 [2] . Owing to the high infectivity and pathogenicity of the virus, COVID-19 has rapidly spread worldwide [3, 4] . Case fatality rate was assessed as high as 1%, which is much greater than seasonal influenza at about 0.1% [5] . In China, the case fatality rate was 17.3% in the early stages of the outbreak and reduced over time to 0.7% after 1 February [6] . With the improvement of monitoring measures and medical treatment methods, the survival rate of patients has been greatly improved. However, there were still a small number of patients died within a short period of time after admission, in other words, sudden death. As no vaccine or specific antiviral therapy against COVID-19 has been proven to be effective, it is beneficial to implement supportive therapy to relieve symptoms and protect multiple organ functions. Treating patients at risk of sudden death promptly is essential to reduce mortality. In this study, we collected data of deceased patients with COVID-19 in Tongji Hospital (Wuhan, China). By comprehensively evaluating the demographic, clinical, radiological, and laboratory characteristics between patients who died within 24 hours after admission and those who died over 24 hours after admission, we hope to find valuable markers related to sudden death. This single-center, retrospective study was performed at Tongji Hospital (Wuhan, China), which is a designated hospital to treat patients with COVID-19. All patients in this study were diagnosed with COVID-19 on the basis of World Health Organization interim guidance [7] , and died between January 22 and March 23, 2020. patients who died within 24 hours after admission were defined as sudden deaths, while those who died more than 24 hours after admission were defined as non-sudden deaths. In total, 281 deceased patients with COVID-19 were included, consisting of 28 sudden deaths and 253 non-sudden deaths. This study was approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. Methods for laboratory confirmation of SARS-CoV-2 infection are standardized. Pharyngeal swabs were collected from patients and placed into tubes with virus preservation solution. Total RNA was extracted within two hours using respiratory sample RNA isolation kits (Pfizer or BioGerm, Shanghai, China). Two target genes, open reading frame 1ab (ORF1ab) and nucleocapsid protein (N), were simultaneously amplified and tested by real time RT-PCR assay, which was conducted using SARS-Cov-2 nucleic acid detection kits (BioGerm, Shanghai, China) according to the manufacturer's protocol. The reaction mixture contained 12 μL of reaction buffer, 4 μL of enzyme solution, 4 μL of ORF1ab/N primers solution, 3 μL of RNase-Free Water, and 2 μL of RNA template. The RT-PCR reaction was under the following conditions: incubation at 50°C for 15 minutes and 95°C for 5 minutes, and 40 cycles of denaturation at 95°C for 10 seconds and fluorescence signal acquisition at 55°C for 45 seconds. Results were defined as negative (cycle threshold value >38 or not detected), positive (amplification curve was s-shaped, and cycle threshold value ≤35) and suspicious (amplification curve was s-shaped, and 35